摘要
急性ST段抬高型心肌梗死(ST-segment elevation myocardial infarction, STEMI)是冠心病的严重类型,为致死致残的主要原因。机械开通闭塞血管,达到血运重建是最关键的治疗。再灌注治疗是急性心肌梗死最主要的治疗措施。在发病12小时内开通闭塞冠状动脉,恢复血流,可缩小心肌梗死面积,减少死亡。越早使冠状动脉再通,患者获益越大。“时间就是心肌,时间就是生命”。近年来,在冠心病介入治疗中使用药物涂层球囊(Drug-coated balloon, DCB)已成为一种新的手段。本文就DCB与DES在STEMI治疗中疗效的对比作一综述。
Acute ST segment elevation myocardial infarction (ST-Segment elevation myocardial infarction (STEMI) is a serious type of coronary heart disease and the main cause of death and disability. Me-chanical opening of occluded vessels to achieve revascularization is the most critical treatment. Reperfusion therapy is the most important treatment for acute myocardial infarction. Opening oc-cluded coronary arteries and restoring blood flow within 12 hours of onset can reduce the area of myocardial infarction and reduce death. The sooner the coronary artery is reopened, the greater the benefit of patients. “Time is heart, time is life”. In recent years, the use of drug coated balloon (DCB) in interventional therapy of coronary heart disease has become a new means. This article makes a comprehensive comparison between DCB and DES in the treatment of STEMI.
出处
《临床医学进展》
2022年第8期7393-7399,共7页
Advances in Clinical Medicine
